This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Noven Pharmaceuticals, Inc.. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: Masayuki Suzuki: Innovator in Transdermal Drug Delivery Technologies
Introduction
Masayuki Suzuki is a prominent inventor based in Miami, FL (US). He has made significant contributions to the field of drug delivery technologies, holding a total of 2 patents. His work focuses on innovative methods that enhance the effectiveness of transdermal drug delivery systems.
Latest Patents
Masayuki Suzuki's latest patents include a microneedle device and methods, which describe microneedle devices made from electron beam crosslinked or photocrosslinked polymer materials. These devices are designed for applications such as drug delivery and sampling biological fluids. Another notable patent is for compositions and methods for sustained drug delivery using active transdermal technology. This patent outlines compositions, methods, and devices that utilize anti-healing compounds to prolong the effects of active transdermal technologies.
Career Highlights
Masayuki Suzuki is currently associated with Noven Pharmaceuticals, Inc., where he continues to innovate in the field of drug delivery. His work has been instrumental in developing technologies that improve patient outcomes through more effective medication administration.
Collaborations
He collaborates with various professionals in the industry, including Cormac H Lyons, to further advance the research and development of transdermal drug delivery systems.
Conclusion
Masayuki Suzuki's contributions to the field of drug delivery through his innovative patents and collaborations highlight his role as a key inventor in this important area of healthcare technology. His work continues to pave the way for advancements in effective medication delivery methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
